Aehr Test Systems

AEHR Technology Semiconductor Equipment & Materials

Aehr Test Systems' revenue for fiscal 2026 (year ended May 2026) was $50.0 million, down 15.2% from fiscal 2025. In the quarter to May 2026, revenue grew 33.7%, EPS grew 140.0% and free cash flow grew 133.2%, each against the same quarter a year earlier.

60.60 8.61 −12.44%
Market cap
$2.3B
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
3/9
Altman Z
63.15
Beneish M
−2.28
Dividend safety
n/a

Insider Decisions trades per month

Total sells 63.27
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell 1 — 1 2 — 30 2 — 1 12 — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 2,260.00
Revenue 50.00
Net Income (7.13)
Free Cash Flow (5.38)
Net Debt (116.36)
Current Ratio 10.33 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E 0.00
P/S ratio 37.17 (above 10: high)
P/B ratio 8.47 (above 6: high)
Past 5Y EPS Growth —
This Y EPS Growth 2,426.67% (at or above 15%: strong)
Next Y EPS Growth 112.66% (at or above 15%: strong)
Next Y revenue growth 181.59% (at or above 10%: strong)
Next 5Y EPS Growth 25.99% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 95.10%
10-year low 10-year high
P/B against its own 10 years 71.45%
10-year low 10-year high
EV/Sales against its own 10 years 95.10%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2018 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 2026
Cash 48 49 25 116
Receivables 17 10 14 17
Inventory 24 37 42 41
Other — — — —
89 98 89 184
2023 2024 2025 2026
Payables 9 5 7 7
ST’ Debt — — — —
Other — — — —
16 11 16 18

Compound Annual Growth %

10y 5y 3y
Sales 13.18% 24.67% (8.36%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 80.53% 42.66%

Revenue $m

Aug Nov Feb May Year
’26 — — — — —
’26 11 10 10 19 50
’25 13 13 18 14 59
’24 21 21 8 17 66
’23 11 15 17 22 65
’22 6 10 15 20 51
’21 2 2 5 8 17
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Aug Nov Feb May Year
’26 — — — — —
’26 0 (1) (4) 2 (3)
’25 2 (6) (2) (2) (7)
’24 4 (1) (3) 1 2
’23 5 0 (1) 6 10
’22 2 3 (3) (1) 2
’21 1 (3) 0 0 (3)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Aug Nov Feb May Year
’26 — — — — —
’26 (2) (2) (4) 2 (5)
’25 2 (6) (3) (5) (12)
’24 4 (1) (3) 1 1
’23 5 0 7 (3) 9
’22 2 3 (3) (1) 1
’21 1 (3) 0 0 (3)
Fiscal quarters ending in the months shown.

EPS $

Aug Nov Feb May Year
’26 — — — — —
’26 (0.07) (0.11) (0.10) 0.04 (0.23)
’25 0.02 (0.03) (0.02) (0.10) (0.13)
’24 0.16 0.20 (0.05) 0.81 1.12
’23 0.02 0.13 0.14 0.21 0.50
’22 0.03 0.03 0.08 0.20 0.34
’21 0.00 (0.08) (0.03) 0.02 (0.09)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to May

Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Trend 2027e 2028e 2029e
Price, $
Price, $ Low 2.15 1.30 1.03 1.10 1.94 6.71 17.05 9.83 6.27 20.99

Analyst estimates 2027–2029

Powerpack
High 6.10 3.37 2.33 2.78 27.09 28.00 54.10 26.30 34.35 147.40
People
People Employees 79 86 79 71 79 91 104 115 136 138
Revenue/emp, $m 0.24 0.34 0.27 0.31 0.21 0.56 0.62 0.58 0.43 0.36
Income, $m
Income, $m Revenue 19 30 21 22 17 51 65 66 59 50
Gross margin, % 35.88 41.91 36.10 37.55 36.34 46.56 50.41 49.15 40.59 35.30
EBT (6) 0 (5) (3) (2) 10 15 12 (4) (12)
EBT margin, % (29.78) 1.54 (24.73) (12.41) (13.28) 18.77 22.50 18.81 (7.28) (23.47)
Net income (6) 1 (5) (3) (2) 9 15 33 (4) (7)
Depreciation 0 0 0 0 0 1 1 1 3 4
Per share, $
Per share, $ Revenue 1.16 1.36 0.94 0.97 0.71 1.95 2.34 2.30 1.99 1.63
Earnings (0.35) 0.02 (0.23) (0.12) (0.09) 0.36 0.52 1.15 (0.13) (0.23)
Cash flow (0.28) (0.06) (0.25) (0.09) (0.12) 0.06 0.36 0.06 (0.25) (0.11)
Capex (0.03) (0.03) (0.01) (0.01) (0.01) (0.02) (0.05) (0.03) (0.17) (0.07)
Free cash flow (0.31) (0.09) (0.26) (0.10) (0.12) 0.04 0.31 0.03 (0.42) (0.18)
Book value 1.03 0.89 0.69 0.61 0.49 1.96 2.72 3.87 4.15 7.16
Shares, m 16 22 22 23 23 26 28 29 30 31
Valuation, ×
Valuation, × P/E 0.00 111.59 0.00 0.00 0.00 23.94 63.50 10.10 0.00 0.00
P/S 3.94 1.91 1.86 1.67 3.55 4.29 14.12 5.01 4.85 57.42
P/B 4.44 2.93 2.54 2.65 5.14 4.28 12.14 2.97 2.33 13.08
EV/Sales 3.41 1.76 1.90 1.50 3.38 3.71 13.41 4.29 4.46 55.13
EV/FCF (12.98) (26.98) (6.89) (15.34) (19.18) 172.51 100.75 282.43 (21.23) (512.79)
Cash, $m
Cash, $m Operating cash flow (4) (1) (6) (2) (3) 2 10 2 (7) (3)
Capex 0 (1) 0 0 0 0 (1) (1) (5) (2)
Free cash flow (5) (2) (6) (2) (3) 1 9 1 (12) (5)
Balance, $m
Balance, $m Working capital 21 18 15 14 10 49 73 87 73 167
Total debt 6 6 — 2 2 1 6 — — —
Net debt (12) (11) (5) (4) (3) (31) (48) (49) (25) (116)
Shareholders’ equity 17 19 15 14 11 51 76 112 123 220
Returns, %
Returns, % ROA (27.62) 1.71 (20.03) (13.38) (9.60) 22.50 18.14 29.33 (2.83) (3.61)
ROIC (60.39) 6.69 (31.17) (16.77) (30.58) 24.99 30.19 10.09 (3.61) (8.57)
ROE (70.35) 2.93 (30.14) (18.99) (15.89) 30.27 23.00 35.42 (3.34) (4.16)
Negative figures in brackets.

All 10 years →

Fiscal years to May 2026 · latest quarter May 2026

Charts ten years each

Aehr Test Systems vs peers in Semiconductor Equipment & Materials (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ACLS Axcelis Technologies, Inc. $3.6B 36.1× 59.9× +10.60% (above 0%: growing) −23.23% (below 0%: shrinking) −60.74% (below 0%: shrinking) 42.38% 9.43% Compare
IPGP IPG Photonics Corporation $3.1B 108× 82.3× +11.11% (above 0%: growing) −25.00% (below 0%: shrinking) +200.46% (above 0%: growing) 40.39% 1.63% Compare
AMBA Ambarella, Inc. $2.8B — (loss-making) — (loss-making) +13.21% (above 0%: growing) n/m −612.08% (below 0%: shrinking) 57.73% (7.53%) Compare
VECO Veeco Instruments Inc. $2.8B 113× 57.6× +16.48% (above 0%: growing) −5.00% (below 0%: shrinking) +776.15% (above 0%: growing) 38.68% 6.13% Compare
COHU Cohu, Inc. $2.6B — (loss-making) — (loss-making) +38.37% (above 0%: growing) n/m −39.36% (below 0%: shrinking) 45.36% 0.20% Compare
UCTT Ultra Clean Holdings, Inc. $2.5B — (loss-making) 98.9× +24.31% (above 0%: growing) n/m −558.40% (below 0%: shrinking) 16.08% 4.57% Compare
AEHR Aehr Test Systems $2.3B — (loss-making) — (loss-making) +33.69% (above 0%: growing) n/m +133.16% (above 0%: growing) 42.57% (6.40%)
ICHR Ichor Holdings, Ltd. $1.8B — (loss-making) 93.0× +22.68% (above 0%: growing) n/m −59.76% (below 0%: shrinking) 13.90% 2.44% Compare
PLAB Photronics, Inc. $1.7B 9.7× 14.0× +2.69% (above 0%: growing) +25.00% (above 0%: growing) +56.06% (above 0%: growing) 33.20% 21.06% Compare
Median of peers $2.7B 71.9× 71.1× +14.85% −14.11% −49.56% 39.54% 3.51%

All 29 Semiconductor Equipment & Materials stocks →

Aehr Test Systems (AEHR) key facts

  • Concern: Aehr Test Systems' revenue for fiscal 2026 (year ended May 2026) was $50.0 million, down 15.2% from fiscal 2025.
  • Aehr Test Systems (AEHR) is a Semiconductor Equipment & Materials company in the Technology sector, listed on Nasdaq.
  • As of October 16, 2026, AEHR traded at $60.60, a market capitalization of $2.3 billion.
  • Return on equity was −4.16% and debt-to-equity 0.00.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 63.15 (safe zone) for fiscal 2026.

Source: company filings (standardised) and stockrow calculations.

Aehr Test Systems (AEHR) Latest News

stockrow.com/AEHR · Data as of May 31, 2026 · For information only; not investment advice. · © 2026 stockrow.com